Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Lo

Showing results (301-310 of 437) with videos related to

Pageof 44
Sort By:
RNA (New York, N.Y.)|October 31, 2022
Human PRPF39 is an alternative splicing factor recruiting U1 snRNP to weak 5' splice sitesSara Espinosa, Francesca De Bortoli, Xueni Li, et al.
Cytotherapy|May 15, 2003
Adoptive cellular immunotherapy for non-small cell lung cancer: a pilot studyB Chan, W Lee, C X L Hu, et al.
Annali Italiani Di Chirurgia|June 25, 2003
[Prognostic markers of the epithelial tumors of the large intestine]A Forte, A D'Urso, L S Gallinaro, et al.
Synapse (New York, N.Y.)|October 6, 2000
Differential effects of acute and short-term lithium administration on dialysate glutamate and GABA levels in the frontal cortex of the conscious ratT Antonelli, V Ferioli, G Lo Gallo, et al.
Annals of Nuclear Medicine|January 15, 2011
Hepatic falciform ligament Tc-99m-macroaggregated albumin activity on SPECT/CT prior to Yttrium-90 microsphere radioembolization: prophylactic measures to prevent non-target microsphere localization via patent hepatic falciform arteriesYung Hsiang Kao, Andrew E H Tan, Li Ser Khoo, et al.
Minerva Medica|January 1, 1992
[Mitral valve prolapse. Age and sex incidence, echocardiographic diagnosis and clinical and electrocardiographic correlations]A Gemelli, M Marilungo, S De Ruvo, et al.
Cancer|July 1, 1987
Intermittent pelvic arterial infusion with peptichemio, doxorubicin, and cisplatin for locally advanced and recurrent carcinoma of the uterine cervixC Scarabelli, S Tumolo, A De Paoli, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1989
Buserelin treatment of advanced prostatic cancer: a phase II studyA Veronesi, G Lo Re, V Dal Bo, et al.
European Urology|January 1, 1992
Buserelin treatment of advanced prostatic carcinoma: prognostic factor analysisA Veronesi, G Lo Re, V Dal Bo, et al.
Scientific Reports|June 9, 2019
The pre-hatching bovine embryo transforms the uterine luminal metabolite composition in vivoMariana Sponchiado, Angela M Gonella-Diaza, Cecília C Rocha, et al.
Pageof 44

Showing results (301-310 of 437) with videos related to

Sort By:
Pageof 44
RNA (New York, N.Y.)|October 31, 2022
Human PRPF39 is an alternative splicing factor recruiting U1 snRNP to weak 5' splice sitesSara Espinosa, Francesca De Bortoli, Xueni Li, et al.
Cytotherapy|May 15, 2003
Adoptive cellular immunotherapy for non-small cell lung cancer: a pilot studyB Chan, W Lee, C X L Hu, et al.
Annali Italiani Di Chirurgia|June 25, 2003
[Prognostic markers of the epithelial tumors of the large intestine]A Forte, A D'Urso, L S Gallinaro, et al.
Synapse (New York, N.Y.)|October 6, 2000
Differential effects of acute and short-term lithium administration on dialysate glutamate and GABA levels in the frontal cortex of the conscious ratT Antonelli, V Ferioli, G Lo Gallo, et al.
Annals of Nuclear Medicine|January 15, 2011
Hepatic falciform ligament Tc-99m-macroaggregated albumin activity on SPECT/CT prior to Yttrium-90 microsphere radioembolization: prophylactic measures to prevent non-target microsphere localization via patent hepatic falciform arteriesYung Hsiang Kao, Andrew E H Tan, Li Ser Khoo, et al.
Minerva Medica|January 1, 1992
[Mitral valve prolapse. Age and sex incidence, echocardiographic diagnosis and clinical and electrocardiographic correlations]A Gemelli, M Marilungo, S De Ruvo, et al.
Cancer|July 1, 1987
Intermittent pelvic arterial infusion with peptichemio, doxorubicin, and cisplatin for locally advanced and recurrent carcinoma of the uterine cervixC Scarabelli, S Tumolo, A De Paoli, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1989
Buserelin treatment of advanced prostatic cancer: a phase II studyA Veronesi, G Lo Re, V Dal Bo, et al.
European Urology|January 1, 1992
Buserelin treatment of advanced prostatic carcinoma: prognostic factor analysisA Veronesi, G Lo Re, V Dal Bo, et al.
Scientific Reports|June 9, 2019
The pre-hatching bovine embryo transforms the uterine luminal metabolite composition in vivoMariana Sponchiado, Angela M Gonella-Diaza, Cecília C Rocha, et al.
Pageof 44